Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

BACKGROUND: A preparatory regimen consisting of thiotepa-busulfan-fludarabine (TBF) has been associated with reduced relapse in patients with haematological malignancies after haploidentical and cord blood transplants; however, few data exist regarding TBF conditioning in sibling (MSD) and unrelated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Saraceni, Francesco, Labopin, Myriam, Hamladji, Rose-Marie, Mufti, Ghulam, Socié, Gerard, Shimoni, Avichai, Delage, Jeremy, Deconinck, Eric, Chevallier, Patrice, Blaise, Didier, Sanz, Jaime, Huynh, Anne, Forcade, Edouard, Savani, Bipin N., Mohty, Mohamad, Nagler, Arnon
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790470/
https://ncbi.nlm.nih.gov/pubmed/29423053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23273
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars